FDA Introduces a Potential Review Architecture for Generative AI-Enabled Medical Devices

FDA Introduces a Potential Review Architecture for Generative AI-Enabled Medical Devices


Key Takeaways

The U.S. Food and Drug Administration (FDA) has issued a discussion paper on how it may approach generative AI (GenAI)-enabled medical devices, proposing a two-axis risk framework and…



Content Curated Originally From Here